EDAP’s Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Congresses
28 juin 2022 09h00 HE
|
EDAP TMS S.A.
LYON, France, June 28, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced its participation to two major forthcoming...
EDAP holds a Symposium at 6th European Endometriosis Congress
14 juin 2022 08h00 HE
|
EDAP TMS S.A.
LYON, France, June 14, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Prof. Gil Dubernard, Head of the Gynecology...
EDAP Announces Multiple Oral Presentations at the 21st International Symposium on Therapeutic Ultrasound
06 juin 2022 08h00 HE
|
EDAP TMS S.A.
LYON, France, June 6, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that three oral presentations will be delivered on its...
EDAP Reports First Quarter 2022 Results
17 mai 2022 16h35 HE
|
EDAP TMS S.A.
First quarter 2022 revenue of approximately EUR 13.0 million (USD 14.5 million), an increase of 26% as compared to EUR 10.3 million (USD 12.4 million) for the first quarter 2021Four Focal One units...
EDAP TMS SA to Announce First Quarter 2022 Financial Results on May 17, 2022
10 mai 2022 08h30 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on, Wednesday, May 18th at 8:30 am EDT LYON, France, May 10, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)
05 mai 2022 08h30 HE
|
EDAP TMS S.A.
AUA is the largest annual gathering of urologists worldwide LYON, France, May 5, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies,...
EDAP Provides Corporate Update on US Focal One® Installation Growth
12 avr. 2022 08h00 HE
|
EDAP TMS S.A.
Company announces Focal One® placements at three renowned academic institutions in March LYON, France, April 12, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in...
EDAP Reports Fourth Quarter and Full Year 2021 Results
30 mars 2022 16h35 HE
|
EDAP TMS S.A.
Full year revenue of approximately EUR 44.1 million (USD 51.9 million) as compared to EUR 41.7 million (USD 47.8 million) for the full year 2020Full year US HIFU treatment volumes increased 65% over...
EDAP TMS SA to Announce Fourth Quarter 2021 Financial Results on Wednesday, March 30, 2022
21 mars 2022 08h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, March 31, at 8:30 am ET LYON, France, March 21, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today...
EDAP Issues Letter to Shareholders
01 févr. 2022 08h00 HE
|
EDAP TMS S.A.
LYON, France, February 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today issued the following letter to shareholders: To my...